Every year bacteria kill more than a million people worldwide through infections that no longer respond to antibiotics. In many cases, why those bacteria are so hard to stop comes down to their uniquely powerful structure.

1 Jul 2026

New Study Defines Molecular Features That Guide the Oncogenic Enzyme Called NSUN2

An RNA-modifying enzyme linked to cancer and neurological disorders selects its targets by recognizing specific RNA shapes and sequences, according to a study by UT Southwestern Medical Center researchers. The findings, published in Nature, define the molecular features that guide the enzyme, NSUN2, to the RNAs it modifies and could help researchers investigate how abnormal RNA modification contributes to disease.

1 Jul 2026

High Stomach Regeneration Rates Can Trigger Tumor Development

Few areas of the body face more daily stress and potential damage than the stomach, which must manage everything we swallow. Along with this constant strain, the stomach also produces acid that can damage its own lining and increase the risk of ulcers.

1 Jul 2026

Single Breast Milk Molecule Reprograms Infant Immune Cells

Trans-vaccenic acid (TVA), the most abundant trans fatty acid found in human breast milk, helps boost immune system development and has long-lasting effects on immune system health in mice, according to a new study by researchers from the University of Chicago.

1 Jul 2026

Researchers Identify Crucial Cell Death in Down Syndrome

Researchers at the Alzheimer's Center at Temple have identified evidence of a new form of cell death known as necroptosis in the brains of individuals with Down Syndrome, with the corresponding biomarkers providing new clues to potential treatment also for Alzheimer's and other neurodegenerative diseases.

1 Jul 2026

New SRV2 Viral Vector Boosts CAR-T Cell Production Efficiency

A Korean research team has developed a new viral vector technology that significantly improves the production efficiency of next-generation cell and gene therapies known as CAR immune cell therapies, which are designed to recognize and destroy cancer cells.

1 Jul 2026

Chinese Researchers Map Greek Oregano Genome for Better Agriculture

Oregano belongs to the Lamiaceae family, which includes many aromatic and medicinal plants.

30 Jun 2026

New Study Explains How Blood Cancer Cells Invade the Lungs

Led by NYU Langone Health researchers, a new study shows how blood cancer cells enter the lungs, damage tissue, and cause severe breathing problems.

30 Jun 2026

Scripps Scientists Find Key Vulnerability in Drug-Resistant Enterococcus Strains

Antibiotic resistance is one of the most urgent threats to global health, linked to an estimated 4.7 million deaths worldwide in 2019 alone.

30 Jun 2026

Using DNA to Save Nature: Europe's Next Biodiversity Frontier

A landmark alliance of DNA experts across Europe signals the start of an unprecedented effort to build a continent-wide system that applies genomics for protecting European biodiversity.

30 Jun 2026

First Atomic Level Images Reveal Blueprint for Better RNA Drugs

RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.

30 Jun 2026

Researchers Develop Non-Toxic Way to Generate the Symptoms of Parkinson's Disease

Scientists usually use animal models when studying Parkinson's disease because these models mimic the disease well.

30 Jun 2026

Melatonin Enhances Random Skin Flap Viability by Suppressing Ferroptosis

Random-pattern skin flaps are widely used to repair defects caused by trauma, burns, tumor removal, and other injuries because they can be designed without depending on a single named blood vessel.

29 Jun 2026

Single Nucleus RNA Sequencing Decodes Tomato Plant Early Stage Development

Seedling emergence is one of the most vulnerable stages in plant life. In darkness, seedlings undergo skotomorphogenesis, forming elongated hypocotyls and curved apical hooks that protect the shoot tip as it pushes through soil.

29 Jun 2026

Advanced Bioinformatics Models Reveal Bacterial Function in Colon Cancer Patients

Over the past two decades, high‑throughput sequencing has dramatically expanded our understanding of the gut microbiome's composition.

29 Jun 2026

Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and consumables, today entered into a definitive agreement pursuant to which Merck KGaA, Darmstadt, Germany, will, subject to customary closing conditions, acquire Bio-Techne for US$73 per share in cash, representing a total enterprise value of approximately US$11.3 billion (EUR 9.9 billion), a 36% premium to Bio-Techne's one-month volume weighted average trading price.

From Bio-Techne 26 Jun 2026